Skip to content
Lower risk Medical device recall · FDA · Published January 9, 2025

Medtronic A820 myPTM App Recall: Delayed Patient Pump Interaction

Medtronic recalls A820 myPTM software for SynchroMed pumps due to delayed patient interactions with implantable pumps. Affected units have specific version and UDI/DI numbers.

🇺🇸 FDA recall #Z-1506-2025Medical deviceMedtronic Neuromodulation ›
Take action

Contact the company

Recalling firmMedtronic Neuromodulation7000 Central Ave Ne · Minneapolis, MN 55432-3568
✎ GovInfoNow plain-language explainer

Medtronic is recalling the A820 myPTM software application for SynchroMed pumps because patients report it takes longer than expected to interact with their implantable pumps. This could cause delays in managing the pump's function, which may impact patient care. Read more at govinfonow.com/recall/53137-medtronic-a820-myptm-app-recall-delayed-patient-pump-interaction.

Source Summary by GovInfoNow · govinfonow.com/recall/53137-medtronic-a820-myptm-app-recall-delayed-patient-pump-interaction · Updated August 18, 2026 · FDA enforcement record: FDA #Z-1506-2025

Cite this page

“Medtronic A820 myPTM App Recall: Delayed Patient Pump Interaction.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/53137-medtronic-a820-myptm-app-recall-delayed-patient-pump-interaction. Based on FDA recall #Z-1506-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1506-2025%22&limit=1).

The FDA announced on Jan. 9, 2025, that Medtronic Neuromodulation is recalling the A820 myPTM Software Application associated with the SynchroMed Pump and Infusion System due to a hazard involving delayed patient interaction with their implantable pump.

How to tell if you have it

  • Brand: Medtronic Neuromodulation
  • Product: A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System
  • Version: v.2x
  • UDI/DI: 00763000632793

The hazard

Product complaints describe the A820 myPTM app taking longer than expected for patients to interact with their implantable pump. The record does not report specific incidents or injuries.

Context

GovInfoNow's records show Medtronic Neuromodulation has 45 other recalls on record since Aug. 9, 2017. Recent brand recalls include the Pocket Adaptor Kits with Incorrect Use-By Dates recalled on May 13, 2026, and the SynchroMed Flex Infusion Software Issue recalled on April 8, 2026. Other recent recalls of similar products include the MiniMed 780G Recall for a software error stopping insulin delivery (Nov. 2, 2025) and the MiniMed 780G Insulin Pump Recall for software error causing insulin stoppage (May 27, 2026).

How to tell if you have this one

Check if your SynchroMed pump uses the A820 myPTM software version v.2x. The specific UDI/DI number 00763000632793 identifies affected units.

  • Brand
    Medtronic Neuromodulation
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Software Version

    Verify your pump uses the A820 myPTM software version v.2x.

  2. Identify UDI/DI Number

    Check the UDI/DI number on your pump's label; affected units have 00763000632793.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Canary Islands, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: Jan 9, 202512. FDA classified it Class II: Apr 1, 202523. Published in FDA’s Enforcement Report: Apr 9, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1506-2025 (January 9, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1506-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA